GenomeSmart announced today a pilot program with ASPiRA LABS®, where GenomeBrain™ will be offered to a select group of providers to improve identification of patients who are at risk for hereditary cancer

NorthBay Healthcare, an independent nonprofit health system in Northern California, has selected the GenomeBrain Platform for a pilot program planned to improve the routine use of genetic testing in patient care.

GenomeSmart, a Silicon Valley-based company delivering the first AI-powered genetic risk assessment and test recommendation platform that simplifies and reduces the burden of providing genetic assessment.

GenomeSmart, a Silicon Valley-based company developing a platform technology to simplify and enable cost-effective and medically responsible broad use of genetic testing in healthcare.

The GenomeBrain platform uses machine learning to compare a patient's personal and medical data with medical guidelines databases and available DNA test types.

GenomeSmart™ Announces the Launch of GenomeBrain™, a Comprehensive Genetic Test Recommendation Platform, Designed to Simplify and Support the Expanded Use of Genetic Testing in Healthcare

GenomeSmart, a Los Altos, California-based company launched the GenomeBrain platform, which was developed with input from genetic counselors and is designed to mimic what they do during the pretest process.